Toll-Like Receptor Signaling in the Liver

Gastroenterology

Volumn 130, Issue 6, 2006, Pages 1886-1900

  Schwabe, Robert F ^a   Seki, Ekihiro ^a   Brenner, David A ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ARTICLE; AUTOIMMUNE DISEASE; CELL POPULATION; DENDRITIC CELL; ENDOTHELIUM CELL; EPITHELIUM CELL; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KUPFFER CELL; LIVER; LIVER CELL; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; LIVER ISCHEMIA; LIVER REGENERATION; LIVER SINUSOID; NONALCOHOLIC FATTY LIVER; NONHUMAN; PARTIAL HEPATECTOMY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REPERFUSION INJURY; STELLATE CELL; VIRUS INFECTION;

EID: 33646347356     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.01.038     Document Type: Article

References (156)

1. Aderem A., and Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 406 (2000) 782-787
2. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu Rev Immunol 20 (2002) 197-216
3. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., and Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86 (1996) 973-983
4. Roach J.C., Glusman G., Rowen L., Kaur A., Purcell M.K., Smith K.D., Hood L.E., and Aderem A. The evolution of vertebrate Toll-like receptors. Proc Natl Acad Sci U S A 102 (2005) 9577-9582
5. Schnare M., Barton G.M., Holt A.C., Takeda K., Akira S., and Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2 (2001) 947-950
6. Mathison J.C., and Ulevitch R.J. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol 123 (1979) 2133-2143
7. Ruiter D.J., van der Meulen J., Brouwer A., Hummel M.J., Mauw B.J., van der Ploeg J.C., and Wisse E. Uptake by liver cells of endotoxin following its intravenous injection. Lab Invest 45 (1981) 38-45
8. Benacerraf B., Sebestyen M.M., and Schlossman S. A quantitative study of the kinetics of blood clearance of P32-labelled Escherichia coli and Staphylococci by the reticuloendothelial system. J Exp Med 110 (1959) 27-48
9. Fox E.S., Thomas P., and Broitman S.A. Clearance of gut-derived endotoxins by the liver. Release and modification of 3H, 14C-lipopolysaccharide by isolated rat Kupffer cells. Gastroenterology 96 (1989) 456-461
10. Gregory S.H., and Wing E.J. Neutrophil-Kupffer-cell interaction in host defenses to systemic infections. Immunol Today 19 (1998) 507-510
11. van Egmond M., van Garderen E., van Spriel A.B., Damen C.A., van Amersfoort E.S., van Zandbergen G., van Hattum J., Kuiper J., and van de Winkel J.G. FcαRI-positive liver Kupffer cells. reappraisal of the function of immunoglobulin A in immunity. Nat Med 6 (2000) 680-685
12. Mehal W.Z., Azzaroli F., and Crispe I.N. Immunology of the healthy liver. old questions and new insights. Gastroenterology 120 (2001) 250-260
13. Crispe I.N. Hepatic T cells and liver tolerance. Nat Rev Immunol 3 (2003) 51-62
14. De Creus A., Abe M., Lau A.H., Hackstein H., Raimondi G., and Thomson A.W. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J Immunol 174 (2005) 2037-2045
15. Lichtman S.N., Wang J., and Lemasters J.J. LPS receptor CD14 participates in release of TNF-α in RAW 264.7 and peritoneal cells but not in Kupffer cells. Am J Physiol 275 (1998) G39-G46
16. Zarember K.A., and Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 168 (2002) 554-561
17. Gao J.J., Diesl V., Wittmann T., Morrison D.C., Ryan J.L., Vogel S.N., and Follettie M.T. Regulation of gene expression in mouse macrophages stimulated with bacterial CpG-DNA and lipopolysaccharide. J Leukoc Biol 72 (2002) 1234-1245
18. Wells C.A., Ravasi T., Faulkner G.J., Carninci P., Okazaki Y., Hayashizaki Y., Sweet M., Wainwright B.J., and Hume D.A. Genetic control of the innate immune response. BMC Immunol 4 (2003) 5
19. Haziot A., Ferrero E., Kontgen F., Hijiya N., Yamamoto S., Silver J., Stewart C.L., and Goyert S.M. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4 (1996) 407-414
20. Jiang Z., Georgel P., Du X., Shamel L., Sovath S., Mudd S., Huber M., Kalis C., Keck S., Galanos C., Freudenberg M., and Beutler B. CD14 is required for MyD88-independent LPS signaling. Nat Immunol 6 (2005) 565-570
21. Nagai Y., Akashi S., Nagafuku M., Ogata M., Iwakura Y., Akira S., Kitamura T., Kosugi A., Kimoto M., and Miyake K. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 3 (2002) 667-672
22. Visintin A., Mazzoni A., Spitzer J.A., and Segal D.M. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc Natl Acad Sci U S A 98 (2001) 12156-12161
23. Ohnishi T., Muroi M., and Tanamoto K. MD-2 is necessary for the toll-like receptor 4 protein to undergo glycosylation essential for its translocation to the cell surface. Clin Diagn Lab Immunol 10 (2003) 405-410
24. Schromm A.B., Lien E., Henneke P., Chow J.C., Yoshimura A., Heine H., Latz E., Monks B.G., Schwartz D.A., Miyake K., and Golenbock D.T. Molecular genetic analysis of an endotoxin nonresponder mutant cell line. a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J Exp Med 194 (2001) 79-88
25. da Silva Correia J., and Ulevitch R.J. MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. J Biol Chem 277 (2002) 1845-1854
26. Schumann R.R., Leong S.R., Flaggs G.W., Gray P.W., Wright S.D., Mathison J.C., Tobias P.S., and Ulevitch R.J. Structure and function of lipopolysaccharide binding protein. Science 249 (1990) 1429-1431
27. Hoebe K., Georgel P., Rutschmann S., Du X., Mudd S., Crozat K., Sovath S., Shamel L., Hartung T., Zahringer U., and Beutler B. CD36 is a sensor of diacylglycerides. Nature 433 (2005) 523-527
28. Michel T., Reichhart J.M., Hoffmann J.A., and Royet J. Drosophila Toll is activated by gram-positive bacteria through a circulating peptidoglycan recognition protein. Nature 414 (2001) 756-759
29. Tanji T., and Ip Y.T. Regulators of the Toll and Imd pathways in the Drosophila innate immune response. Trends Immunol 26 (2005) 193-198
30. Kawai T., Adachi O., Ogawa T., Takeda K., and Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11 (1999) 115-122
31. Horng T., Barton G.M., Flavell R.A., and Medzhitov R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420 (2002) 329-333
32. Yamamoto M., Sato S., Hemmi H., Sanjo H., Uematsu S., Kaisho T., Hoshino K., Takeuchi O., Kobayashi M., Fujita T., Takeda K., and Akira S. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420 (2002) 324-329
33. Hoebe K., Du X., Georgel P., Janssen E., Tabeta K., Kim S.O., Goode J., Lin P., Mann N., Mudd S., Crozat K., Sovath S., Han J., and Beutler B. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424 (2003) 743-748
34. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K., and Akira S. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301 (2003) 640-643
35. Yamamoto M., Sato S., Hemmi H., Uematsu S., Hoshino K., Kaisho T., Takeuchi O., Takeda K., and Akira S. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 4 (2003) 1144-1150
36. Suzuki N., Suzuki S., Duncan G.S., Millar D.G., Wada T., Mirtsos C., Takada H., Wakeham A., Itie A., Li S., Penninger J.M., Wesche H., Ohashi P.S., Mak T.W., and Yeh W.C. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416 (2002) 750-756
37. Swantek J.L., Tsen M.F., Cobb M.H., and Thomas J.A. IL-1 receptor-associated kinase modulates host responsiveness to endotoxin. J Immunol 164 (2000) 4301-4306
38. Sato S., Sanjo H., Takeda K., Ninomiya-Tsuji J., Yamamoto M., Kawai T., Matsumoto K., Takeuchi O., and Akira S. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 6 (2005) 1087-1095
39. Takaoka A., Yanai H., Kondo S., Duncan G., Negishi H., Mizutani T., Kano S., Honda K., Ohba Y., Mak T.W., and Taniguchi T. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434 (2005) 243-249
40. Matsuzawa A., Saegusa K., Noguchi T., Sadamitsu C., Nishitoh H., Nagai S., Koyasu S., Matsumoto K., Takeda K., and Ichijo H. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol 6 (2005) 587-592
41. Covert M.W., Leung T.H., Gaston J.E., and Baltimore D. Achieving stability of lipopolysaccharide-induced NF-κB activation. Science 309 (2005) 1854-1857
42. Werner S.L., Barken D., and Hoffmann A. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309 (2005) 1857-1861
43. Burns K., Janssens S., Brissoni B., Olivos N., Beyaert R., and Tschopp J. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J Exp Med 197 (2003) 263-268
44. Uematsu S., Sato S., Yamamoto M., Hirotani T., Kato H., Takeshita F., Matsuda M., Coban C., Ishii K.J., Kawai T., Takeuchi O., and Akira S. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon (α) induction. J Exp Med 201 (2005) 915-923
45. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., and Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 (2005) 772-777
46. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.M., and Maniatis T. IKKε{lunate} and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4 (2003) 491-496
47. McWhirter S.M., Fitzgerald K.A., Rosains J., Rowe D.C., Golenbock D.T., and Maniatis T. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc Natl Acad Sci U S A 101 (2004) 233-238
48. Shimada T., Kawai T., Takeda K., Matsumoto M., Inoue J., Tatsumi Y., Kanamaru A., and Akira S. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IκB kinases. Int Immunol 11 (1999) 1357-1362
49. Hemmi H., Takeuchi O., Sato S., Yamamoto M., Kaisho T., Sanjo H., Kawai T., Hoshino K., Takeda K., and Akira S. The roles of two IκB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J Exp Med 199 (2004) 1641-1650
50. Meylan E., Burns K., Hofmann K., Blancheteau V., Martinon F., Kelliher M., and Tschopp J. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κB activation. Nat Immunol 5 (2004) 503-507
51. Sato S., Sugiyama M., Yamamoto M., Watanabe Y., Kawai T., Takeda K., and Akira S. Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-κB and IFN-regulatory factor-3, in the Toll-like receptor signaling. J Immunol 171 (2003) 4304-4310
52. Jiang Z., Zamanian-Daryoush M., Nie H., Silva A.M., Williams B.R., and Li X. Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFκB and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR. J Biol Chem 278 (2003) 16713-16719
53. Gohda J., Matsumura T., and Inoue J. Cutting edge. TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-β (TRIF)-dependent pathway in TLR signaling. J Immunol 173 (2004) 2913-2917
54. Liew F.Y., Xu D., Brint E.K., and O'Neill L.A. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 5 (2005) 446-458
55. Nomura F., Akashi S., Sakao Y., Sato S., Kawai T., Matsumoto M., Nakanishi K., Kimoto M., Miyake K., Takeda K., and Akira S. Cutting edge. endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol 164 (2000) 3476-3479
56. Akashi S., Shimazu R., Ogata H., Nagai Y., Takeda K., Kimoto M., and Miyake K. Cutting edge. cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol 164 (2000) 3471-3475
57. Chuang T.H., and Ulevitch R.J. Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors. Nat Immunol 5 (2004) 495-502
58. Brint E.K., Xu D., Liu H., Dunne A., McKenzie A.N., O'Neill L.A., and Liew F.Y. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol 5 (2004) 373-379
59. Wald D., Qin J., Zhao Z., Qian Y., Naramura M., Tian L., Towne J., Sims J.E., Stark G.R., and Li X. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 4 (2003) 920-927
60. Janssens S., Burns K., Vercammen E., Tschopp J., and Beyaert R. MyD88S, a splice variant of MyD88, differentially modulates NF-κB- and AP-1-dependent gene expression. FEBS Lett 548 (2003) 103-107
61. Kobayashi K., Hernandez L.D., Galan J.E., Janeway Jr. C.A., Medzhitov R., and Flavell R.A. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110 (2002) 191-202
62. Hardy M.P., and O'Neill L.A. The murine IRAK2 gene encodes four alternatively spliced isoforms, two of which are inhibitory. J Biol Chem 279 (2004) 27699-27708
63. Nakagawa R., Naka T., Tsutsui H., Fujimoto M., Kimura A., Abe T., Seki E., Sato S., Takeuchi O., Takeda K., Akira S., Yamanishi K., Kawase I., Nakanishi K., and Kishimoto T. SOCS-1 participates in negative regulation of LPS responses. Immunity 17 (2002) 677-687
64. Dalpke A.H., Opper S., Zimmermann S., and Heeg K. Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs. J Immunol 166 (2001) 7082-7089
65. Kinjyo I., Hanada T., Inagaki-Ohara K., Mori H., Aki D., Ohishi M., Yoshida H., Kubo M., and Yoshimura A. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17 (2002) 583-591
66. Su G.L., Klein R.D., Aminlari A., Zhang H.Y., Steinstraesser L., Alarcon W.H., Remick D.G., and Wang S.C. Kupffer cell activation by lipopolysaccharide in rats. role for lipopolysaccharide binding protein and toll-like receptor 4. Hepatology 31 (2000) 932-936
67. Van Bossuyt H., De Zanger R.B., and Wisse E. Cellular and subcellular distribution of injected lipopolysaccharide in rat liver and its inactivation by bile salts. J Hepatol 7 (1988) 325-337
68. Seki E., Tsutsui H., Nakano H., Tsuji N., Hoshino K., Adachi O., Adachi K., Futatsugi S., Kuida K., Takeuchi O., Okamura H., Fujimoto J., Akira S., and Nakanishi K. Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1β. J Immunol 166 (2001) 2651-2657
69. Kopydlowski K.M., Salkowski C.A., Cody M.J., van Rooijen N., Major J., Hamilton T.A., and Vogel S.N. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J Immunol 163 (1999) 1537-1544
70. Tsutsui H., Matsui K., Okamura H., and Nakanishi K. Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol Rev 174 (2000) 192-209
71. Seki E., Tsutsui H., Tsuji N.M., Hayashi N., Adachi K., Nakano H., Futatsugi-Yumikura S., Takeuchi O., Hoshino K., Akira S., Fujimoto J., and Nakanishi K. Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J Immunol 169 (2002) 3863-3868
72. Knolle P., Schlaak J., Uhrig A., Kempf P., Meyer zum Buschenfelde K.H., and Gerken G. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol 22 (1995) 226-229
73. Schuchmann M., Hermann F., Herkel J., van der Zee R., Galle P.R., and Lohse A.W. HSP60 and CpG-DNA-oligonucleotides differentially regulate LPS-tolerance of hepatic Kupffer cells. Immunol Lett 93 (2004) 199-204
74. Matsumura T., Degawa T., Takii T., Hayashi H., Okamoto T., Inoue J., and Onozaki K. TRAF6-NF-κB pathway is essential for interleukin-1-induced TLR2 expression and its functional response to TLR2 ligand in murine hepatocytes. Immunology 109 (2003) 127-136
75. Matsumura T., Ito A., Takii T., Hayashi H., and Onozaki K. Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes. J Interferon Cytokine Res 20 (2000) 915-921
76. Li K., Chen Z., Kato N., Gale Jr. M., and Lemon S.M. Distinct poly-I. C and virus-activated signaling pathways leading to interferon-β production in hepatocytes. J Biol Chem 280 (2005) 16739-16747
77. Mimura Y., Sakisaka S., Harada M., Sata M., and Tanikawa K. Role of hepatocytes in direct clearance of lipopolysaccharide in rats. Gastroenterology 109 (1995) 1969-1976
78. Hampton R.Y., Golenbock D.T., Penman M., Krieger M., and Raetz C.R. Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 352 (1991) 342-344
79. Vishnyakova T.G., Bocharov A.V., Baranova I.N., Chen Z., Remaley A.T., Csako G., Eggerman T.L., and Patterson A.P. Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1. J Biol Chem 278 (2003) 22771-22780
80. Bataller R., and Brenner D.A. Liver fibrosis. J Clin Invest 115 (2005) 209-218
81. Paik Y.H., Schwabe R.F., Bataller R., Russo M.P., Jobin C., and Brenner D.A. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37 (2003) 1043-1055
82. Brun P., Castagliuolo I., Pinzani M., Palu G., and Martines D. Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 289 (2005) G571-G578
83. Thirunavukkarasu C., Uemura T., Wang L.F., Watkins S.C., and Gandhi C.R. Normal rat hepatic stellate cells respond to endotoxin in LBP-independent manner to produce inhibitor(s) of DNA synthesis in hepatocytes. J Cell Physiol 204 (2005) 654-665
84. Harada K., Ohira S., Isse K., Ozaki S., Zen Y., Sato Y., and Nakanuma Y. Lipopolysaccharide activates nuclear factor-κB through toll-like receptors and related molecules in cultured biliary epithelial cells. Lab Invest 83 (2003) 1657-1667
85. Chen X.M., O'Hara S.P., Nelson J.B., Splinter P.L., Small A.J., Tietz P.S., Limper A.H., and LaRusso N.F. Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-κB. J Immunol 175 (2005) 7447-7456
86. Uhrig A., Banafsche R., Kremer M., Hegenbarth S., Hamann A., Neurath M., Gerken G., Limmer A., and Knolle P.A. Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver. J Leukoc Biol 77 (2005) 626-633
87. Bjarnason I., Peters T.J., and Wise R.J. The leaky gut of alcoholism. possible route of entry for toxic compounds. Lancet 1 (1984) 179-182
88. Draper L.R., Gyure L.A., Hall J.G., and Robertson D. Effect of alcohol on the integrity of the intestinal epithelium. Gut 24 (1983) 399-404
89. Parlesak A., Schafer C., Schutz T., Bode J.C., and Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol 32 (2000) 742-747
90. Nanji A.A., Khettry U., and Sadrzadeh S.M. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc Soc Exp Biol Med 205 (1994) 243-247
91. Adachi Y., Moore L.E., Bradford B.U., Gao W., and Thurman R.G. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108 (1995) 218-224
92. Adachi Y., Bradford B.U., Gao W., Bojes H.K., and Thurman R.G. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 20 (1994) 453-460
93. Hansen J., Cherwitz D.L., and Allen J.I. The role of tumor necrosis factor-α in acute endotoxin-induced hepatotoxicity in ethanol-fed rats. Hepatology 20 (1994) 461-474
94. Uesugi T., Froh M., Arteel G.E., Bradford B.U., and Thurman R.G. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 34 (2001) 101-108
95. Kono H., Rusyn I., Yin M., Gabele E., Yamashina S., Dikalova A., Kadiiska M.B., Connor H.D., Mason R.P., Segal B.H., Bradford B.U., Holland S.M., and Thurman R.G. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J Clin Invest 106 (2000) 867-872
96. Yang S.Q., Lin H.Z., Lane M.D., Clemens M., and Diehl A.M. Obesity increases sensitivity to endotoxin liver injury. implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A 94 (1997) 2557-2562
97. Solga S.F., and Diehl A.M. Non-alcoholic fatty liver disease. lumen-liver interactions and possible role for probiotics. J Hepatol 38 (2003) 681-687
98. Li Z., Yang S., Lin H., Huang J., Watkins P.A., Moser A.B., Desimone C., Song X.Y., and Diehl A.M. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37 (2003) 343-350
99. Szabo G., Velayudham A., Romics Jr. L., and Mandrekar P. Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice. the role of toll-like receptors 2 and 4. Alcohol Clin Exp Res 29 (2005) S140-S145
100. Igolnikov A.C., Spatz K., and Green R.M. C3H/HeJ mice with mutations of the toll-like receptor 4 (TLR-4) are resistant to methionine-choline deficient (MCD) diet induced non-alcoholic steatohepatitis (NASH). Hepatology 36 (2002) A965
101. Wiest R., and Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 41 (2005) 422-433
102. Chesta J., Defilippi C., and Defilippi C. Abnormalities in proximal small bowel motility in patients with cirrhosis. Hepatology 17 (1993) 828-832
103. Guarner C., Runyon B.A., Young S., Heck M., and Sheikh M.Y. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 26 (1997) 1372-1378
104. Ramachandran A., Prabhu R., Thomas S., Reddy J.B., Pulimood A., and Balasubramanian K.A. Intestinal mucosal alterations in experimental cirrhosis in the rat. role of oxygen free radicals. Hepatology 35 (2002) 622-629
105. Rajkovic I.A., and Williams R. Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology 6 (1986) 252-262
106. Garcia-Tsao G., Lee F.Y., Barden G.E., Cartun R., and West A.B. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 108 (1995) 1835-1841
107. Nolan J.P., and Leibowitz A.I. Endotoxin and the liver. III. Modification of acute carbon tetrachloride injury by polymyxin b-an antiendotoxin. Gastroenterology 75 (1978) 445-449
108. Grinko I., Geerts A., and Wisse E. Experimental biliary fibrosis correlates with increased numbers of fat-storing and Kupffer cells, and portal endotoxemia. J Hepatol 23 (1995) 449-458
109. Chan C.C., Hwang S.J., Lee F.Y., Wang S.S., Chang F.Y., Li C.P., Chu C.J., Lu R.H., and Lee S.D. Prognostic value of plasma endotoxin levels in patients with cirrhosis. Scand J Gastroenterol 32 (1997) 942-946
110. Fukui H., Brauner B., Bode J.C., and Bode C. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease. reevaluation with an improved chromogenic assay. J Hepatol 12 (1991) 162-169
111. Lin R.S., Lee F.Y., Lee S.D., Tsai Y.T., Lin H.C., Lu R.H., Hsu W.C., Huang C.C., Wang S.S., and Lo K.J. Endotoxemia in patients with chronic liver diseases. relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol 22 (1995) 165-172
112. Luckey T.D., Reyniers J.A., Gyorgy P., and Forbes M. Germfree animals and liver necrosis. Ann N Y Acad Sci 57 (1954) 932-935
113. Rutenburg A.M., Sonnenblick E., Koven I., Aprahamian H.A., Reiner L., and Fine J. The role of intestinal bacteria in the development of dietary cirrhosis in rats. J Exp Med 106 (1957) 1-14
114. Seki E., Osawa Y., Uchinami H., Brenner D.A., and Schwabe R.F. TLR4 mediates inflammation and fibrogenesis after bile duct ligation. Hepatology 42 (2005) A265
115. Dolganiuc A., Oak S., Kodys K., Golenbock D.T., Finberg R.W., Kurt-Jones E., and Szabo G. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 127 (2004) 1513-1524
116. Bataller R., Paik Y.H., Lindquist J.N., Lemasters J.J., and Brenner D.A. Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells. Gastroenterology 126 (2004) 529-540
117. Wieland S., Thimme R., Purcell R.H., and Chisari F.V. Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 101 (2004) 6669-6674
118. McClary H., Koch R., Chisari F.V., and Guidotti L.G. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J Virol 74 (2000) 2255-2264
119. Isogawa M., Robek M.D., Furuichi Y., and Chisari F.V. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol 79 (2005) 7269-7272
120. Cooper C.L., Davis H.L., Morris M.L., Efler S.M., Adhami M.A., Krieg A.M., Cameron D.W., and Heathcote J. CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults. a double-blind phase I/II study. J Clin Immunol 24 (2004) 693-701
121. Rehermann B., and Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5 (2005) 215-229
122. Li K., Foy E., Ferreon J.C., Nakamura M., Ferreon A.C., Ikeda M., Ray S.C., Gale Jr. M., and Lemon S.M. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A 102 (2005) 2992-2997
123. Otsuka M., Kato N., Moriyama M., Taniguchi H., Wang Y., Dharel N., Kawabe T., and Omata M. Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses. Hepatology 41 (2005) 1004-1012
124. Machida K., Cheng K.T., Sung V.M., Levine A.M., Foung S., and Lai M.M. Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of Beta interferon and interleukin-6. J Virol 80 (2006) 866-874
125. Horsmans Y., Berg T., Desager J.P., Mueller T., Schott E., Fletcher S.P., Steffy K.R., Bauman L.A., Kerr B.M., and Averett D.R. Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection. Hepatology 42 (2005) 724-731
126. Zhai Y., Shen X.D., O'Connell R., Gao F., Lassman C., Busuttil R.W., Cheng G., and Kupiec-Weglinski J.W. Cutting edge. TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 173 (2004) 7115-7119
127. Tsung A., Sahai R., Tanaka H., Nakao A., Fink M.P., Lotze M.T., Yang H., Li J., Tracey K.J., Geller D.A., and Billiar T.R. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201 (2005) 1135-1143
128. Taub R. Liver regeneration. from myth to mechanism. Nat Rev Mol Cell Biol 5 (2004) 836-847
129. Higgins G.M., and Anderson R.M. Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 12 (1931) 186-202
130. Cornell R.P., Liljequist B.L., and Bartizal K.F. Depressed liver regeneration after partial hepatectomy of germ-free, athymic and lipopolysaccharide-resistant mice. Hepatology 11 (1990) 916-922
131. Su G.L., Wang S.C., Aminlari A., Tipoe G.L., Steinstraesser L., and Nanji A. Impaired hepatocyte regeneration in toll-like receptor 4 mutant mice. Dig Dis Sci 49 (2004) 843-849
132. Seki E., Tsutsui H., Iimuro Y., Naka T., Son G., Akira S., Kishimoto T., Nakanishi K., and Fujimoto J. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology 41 (2005) 443-450
133. Sun R., and Gao B. Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma). Gastroenterology 127 (2004) 1525-1539
134. Shimizu Y., Margenthaler J.A., Landeros K., Otomo N., Doherty G., and Flye M.W. The resistance of P. acnes-primed interferon γ-deficient mice to low-dose lipopolysaccharide-induced acute liver injury. Hepatology 35 (2002) 805-814
135. Galanos C., Freudenberg M.A., and Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A 76 (1979) 5939-5943
136. Jiang W., Sun R., Wei H., and Tian Z. Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages. Proc Natl Acad Sci U S A 102 (2005) 17077-17082
137. Tsuji H., Mukaida N., Harada A., Kaneko S., Matsushita E., Nakanuma Y., Tsutsui H., Okamura H., Nakanishi K., Tagawa Y., Iwakura Y., Kobayashi K., and Matsushima K. Alleviation of lipopolysaccharide-induced acute liver injury in Propionibacterium acnes-primed IFN-γ-deficient mice by a concomitant reduction of TNF-α, IL-12, and IL-18 production. J Immunol 162 (1999) 1049-1055
138. Tsutsui H., Matsui K., Kawada N., Hyodo Y., Hayashi N., Okamura H., Higashino K., and Nakanishi K. IL-18 accounts for both TNF-α- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J Immunol 159 (1997) 3961-3967
139. Kalis C., Gumenscheimer M., Freudenberg N., Tchaptchet S., Fejer G., Heit A., Akira S., Galanos C., and Freudenberg M.A. Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes. J Immunol 174 (2005) 4295-4300
140. Romics Jr. L., Dolganiuc A., Velayudham A., Kodys K., Mandrekar P., Golenbock D., Kurt-Jones E., and Szabo G. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propionibacterium acnes. J Leukoc Biol 78 (2005) 1255-1264
141. Romics Jr. L., Dolganiuc A., Kodys K., Drechsler Y., Oak S., Velayudham A., Mandrekar P., and Szabo G. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice. Hepatology 40 (2004) 555-564
142. Edelson B.T., and Unanue E.R. MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria. no role for either in macrophage listericidal activity. J Immunol 169 (2002) 3869-3875
143. O'Brien A.D., Rosenstreich D.L., Scher I., Campbell G.H., MacDermott R.P., and Formal S.B. Genetic control of susceptibility to Salmonella typhimurium in mice. role of the LPS gene. J Immunol 124 (1980) 20-24
144. Vazquez-Torres A., Vallance B.A., Bergman M.A., Finlay B.B., Cookson B.T., Jones-Carson J., and Fang F.C. Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella. importance of the Kupffer cell network. J Immunol 172 (2004) 6202-6208
145. Totemeyer S., Foster N., Kaiser P., Maskell D.J., and Bryant C.E. Toll-like receptor expression in C3H/HeN and C3H/HeJ mice during Salmonella enterica serovar Typhimurium infection. Infect Immun 71 (2003) 6653-6657
146. Shimizu H., Matsuguchi T., Fukuda Y., Nakano I., Hayakawa T., Takeuchi O., Akira S., Umemura M., Suda T., and Yoshikai Y. Toll-like receptor 2 contributes to liver injury by Salmonella infection through Fas ligand expression on NKT cells in mice. Gastroenterology 123 (2002) 1265-1277
147. Adachi K., Tsutsui H., Kashiwamura S., Seki E., Nakano H., Takeuchi O., Takeda K., Okumura K., Van Kaer L., Okamura H., Akira S., and Nakanishi K. Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J Immunol 167 (2001) 5928-5934
148. Bach J.F. A Toll-like trigger for autoimmune disease. Nat Med 11 (2005) 120-121
149. Kerfoot S.M., Long E.M., Hickey M.J., Andonegui G., Lapointe B.M., Zanardo R.C., Bonder C., James W.G., Robbins S.M., and Kubes P. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J Immunol 173 (2004) 7070-7077
150. Lang K.S., Recher M., Junt T., Navarini A.A., Harris N.L., Freigang S., Odermatt B., Conrad C., Ittner L.M., Bauer S., Luther S.A., Uematsu S., Akira S., Hengartner H., and Zinkernagel R.M. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med 11 (2005) 138-145
151. Patole P.S., Grone H.J., Segerer S., Ciubar R., Belemezova E., Henger A., Kretzler M., Schlondorff D., and Anders H.J. Viral double-stranded RNA aggravates Lupus Nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. J Am Soc Nephrol 16 (2005) 1326-1338
152. Takii Y., Nakamura M., Ito M., Yokoyama T., Komori A., Shimizu-Yoshida Y., Nakao R., Kusumoto K., Nagaoka S., Yano K., Abiru S., Ueki T., Matsumoto T., Daikoku M., Taniguchi K., Fujioka H., Migita K., Yatsuhashi H., Nakashima M., Harada M., and Ishibashi H. Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis. Lab Invest 85 (2005) 908-920
153. Wang A.P., Migita K., Ito M., Takii Y., Daikoku M., Yokoyama T., Komori A., Nakamura M., Yatsuhashi H., and Ishibashi H. Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis. J Autoimmun 25 (2005) 85-91
154. Mao T.K., Lian Z.X., Selmi C., Ichiki Y., Ashwood P., Ansari A.A., Coppel R.L., Shimoda S., Ishibashi H., and Gershwin M.E. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology 42 (2005) 802-808
155. Kikuchi K., Lian Z.X., Yang G.X., Ansari A.A., Ikehara S., Kaplan M., Miyakawa H., Coppel R.L., and Gershwin M.E. Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology 128 (2005) 304-312
156. Kikuchi K., Lian Z.X., Kimura Y., Selmi C., Yang G.X., Gordon S.C., Invernizzi P., Podda M., Coppel R.L., Ansari A.A., Ikehara S., Miyakawa H., and Gershwin M.E. Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis. J Autoimmun 24 (2005) 347-352